| Gene symbol | CD19 | Synonyms | B4, CVID3 | Type of gene | protein-coding |
| Chromosome | 16 | Map location | 16p11.2 | dbXrefs | |
| Description | CD19 molecule | ||||
| GTO ID | GTC2551 |
| Trial ID | NCT04690192 |
| Disease | Large B-Cell Lymphoma |
| Altered gene | CD19 |
| Therapeutic/Target gene | Target gene |
| Therapy | CAR-T cell |
| Treatment | CNCT19|inaticabtagene autoleucel |
| Location approved | China |
| Generation | 2nd |
| Phase | Phase1|Phase2 |
| Recruitment status | Recruiting |
| Title | CNCT19 Following ASCT in Patients With Relapsed or Refractory B-cell Lymphoma |
| Year | 2020 |
| Country | China |
| Company sponsor | Zou Dehui |
| Other ID(s) | IHBDH-IIT002 |
| Cohort 1 | |||||||||
|
|||||||||